Institutional Ownership Achilles Therapeutics PLC (ACHL)
This table provides information about the institutional ownership of Achilles Therapeutics PLC (ACHL). We have compiled data on the 22 institutions that hold shares in the stock, with a total of 24.2 Million shares, which have been reported (via 13F filing form) to have a value of $33.7 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Syncona Portfolio LTD
Guernsey, Channel Islands, X0 |
Feb 06, 2025 Q4 2024 |
11,086,909
shares
|
$15.3 Million
23.86% of portfolio
|
Q4 2021
New holding
|
|
|
Bml Capital Management, LLC
Zionsville, IN |
Feb 06, 2025 Q4 2024 |
4,100,002
shares
|
$5.66 Million
2.9% of portfolio
|
Q3 2024
Added 555.82%
|
|
|
Fcpm Iii Services B.V.
Naarden, P7 |
Feb 14, 2025 Q4 2024 |
2,390,050
shares
|
$3.3 Million
0.46% of portfolio
|
Q4 2023
New holding
|
|
|
Redmile Group, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,608,089
shares
|
$2.22 Million
0.14% of portfolio
|
Q1 2022
Reduced 22.99%
|
|
|
Vestal Point Capital, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,500,000
shares
|
$2.07 Million
0.1% of portfolio
|
Q1 2024
Added 1287.82%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Feb 14, 2025 Q4 2024 |
1,441,141
shares
|
$1.99 Million
0.27% of portfolio
|
Q4 2024
Reduced 0.14%
|
|
|
Siren, L.L.C.
New York, NY |
Feb 14, 2025 Q4 2024 |
755,375
shares
|
$1.04 Million
0.04% of portfolio
|
Q3 2024
New holding
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
547,233
shares
|
$755,181
0.0% of portfolio
|
Q4 2024
Reduced 14.24%
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
418,441
shares
|
$577,448
0.01% of portfolio
|
Q4 2024
Reduced 0.49%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Feb 11, 2025 Q4 2024 |
191,829
shares
|
$264,724
0.0% of portfolio
|
Q4 2024
Reduced 23.52%
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
61,637
shares
|
$85,059
0.0% of portfolio
|
Q4 2024
Added 190.07%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
34,200
shares
|
$47,195
0.0% of portfolio
|
Q4 2024
Added 52.68%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
33,731
shares
|
$46,548
0.0% of portfolio
|
Q4 2024
Added 105.29%
|
|
|
Xtx Topco LTD
London, X0 |
Feb 13, 2025 Q4 2024 |
26,824
shares
|
$37,017
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
21,590
shares
|
$29,794
0.0% of portfolio
|
Q1 2022
Added 22.73%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
15,799
shares
|
$21,802
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Brave Asset Management Inc
|
Jan 14, 2025 Q4 2024 |
10,000
shares
|
$13,799
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Rhumbline Advisers
Boston, MA |
Jan 30, 2025 Q4 2024 |
4,480
shares
|
$6,182
0.0% of portfolio
|
Q2 2024
Added 27.49%
|
|
|
Endurance Wealth Management, Inc.
|
Aug 09, 2023 Q2 2023 |
2,000
shares
|
$2,760
0.0% of portfolio
|
Q1 2023
Added 99900.0%
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Feb 05, 2025 Q4 2024 |
322
shares
|
$444
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
137
shares
|
$189
0.0% of portfolio
|
Q4 2023
Added 621.9%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|